Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.480.02%
QQQ
714.89-
BTC/USD
77620.801.0689%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

ImageneBio Inc

IMANASDAQ
Trade with Public
Trade with Public
$5.08
0.0751.5%
At close: Sep 11, 5:00 PM EST
$5.40
0.326.3%
After Hours: Sep 2, 8:36 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

ImageneBio Analyst Price Targets

Wall Street analyst price targets and consensus rating for ImageneBio (IMA).

Price Target Range — 3 Quarters

Analyst Consensus — 3 Analysts

2Buy
1Sell
Consensus RatingOutperform# Analysts3Avg. Consensus PT$20Upside to Avg. PT+270.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 21, 2026HC Wainwright & Co.Arthur HeInitiateBuy$28
May 11, 2026WedbushMartin Fan MaintainedUnderperform$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Initiates Coverage On ImageneBio with Buy Rating, Announces Price Target of $28

HC Wainwright & Co. analyst Arthur He initiates coverage on ImageneBio (NASDAQ:IMA) with a Buy rating and announces Price Target of $28.
Benzinga Newsdesk

PRO
Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target

Wedbush analyst Martin Fan reiterates ImageneBio (NASDAQ:IMA) with a Underperform and maintains $2 price target.
Benzinga Newsdesk

PRO
Wedbush Assumes ImageneBio at Underperform, Announces Price Target of $2

Wedbush analyst Martin Fan assumes ImageneBio (NASDAQ:IMA) with a Underperform rating and announces Price Target of $2.
Benzinga Newsdesk

This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Leerink Partners Initiates Coverage On ImageneBio with Outperform Rating, Announces Price Target of $30

Leerink Partners analyst David Risinger initiates coverage on ImageneBio (NASDAQ:IMA) with a Outperform rating and announces Price Target of $30.
Benzinga Newsdesk

Jefferies Global Life Sciences Conference Takeaways; Diagnostics

Benzinga

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved